NCT06299540 2026-03-13
QOLIBRI
Janssen Cilag S.A.S.
Recruiting
Clinical Trials
4 trialsNCT03476655 2025-02-03
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India
Johnson & Johnson Private Limited
Completed
NCT03425591 2022-10-06
FIRE
Janssen-Cilag Ltd.
Completed
NCT03720561 2022-01-03
EVIdeNCE
Janssen-Cilag S.p.A.
Completed